It has been a week since Microsoft released Windows 11 version 25H2, the newest feature update for the OS. In case you ...
U.S. drugmaker Biogen Inc and gene-editing startup Scribe Therapeutics Inc will jointly develop therapies for treating underlying genetic causes of amyotrophic lateral sclerosis (ALS), a fatal ...
CorMedix surged on strong DefenCath sales and a Melinta acquisition. I maintain a Sell rating on CRMD stock, citing ...
The Central and Eastern Europe Fund, Inc. remains attractive with low portfolio P/E of 8.58x and 12% earnings yield. Read why ...
Roach’s visit is part of the National Endowment for the Arts Big Read, which includes a series of community programs centered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback